Back to search

Article

<i>Ex vivo</i> therapeutic base and prime editing using chemically derived hepatic progenitors in a mouse model of tyrosinemia type 1

2020-09-15

Abstract excerpt

<h4>Summary</h4> DNA base editors and prime editing technology capable of therapeutic base conversion enable ex vivo gene editing therapy for various genetic diseases. For such therapy, it is critical that the target cells survive well both outside the body and after transplantation. In this regard, chemically derived stem/progenitor cells are attracting attention as the most useful cell sources for clinical tri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c378b658-60c3-5c76-8c0e-0ab4a78d1e47
DOI
10.1101/2020.09.14.297275
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>Ex vivo</i> therapeutic base and prime editing using chemically derived hepatic progenitors in a mouse model of tyrosinemia type 1DOI 10.1101/2020.09.14.297275
Select a neighboring publication to make it the new centre.